Review article · 2023 · Open access

The role of immune activation and antigen persistence in acute and long COVID

Skye Opsteen, Jacob K. Files, Tim Fram, Nathan B. Erdmann

Journal of Investigative Medicine, 71(5), 545–562 · Published 6 March 2023 · DOI 10.1177/10815589231158041

Open PDFView at the publisherCite this paper

In brief

“The role of immune activation and antigen persistence in acute and long COVID” is a 2023 review article by Skye Opsteen and 3 co-authors, published in Journal of Investigative Medicine. OpenAlex counts 73 citations as of 18 November 2026, which puts it in the top 1% of works published in 2023 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
73
Most cited in
2024 (28)
Field-weighted impact
2.56
References
253
Authors
4

Abstract

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the global coronavirus disease 2019 (COVID-19) pandemic. Although most infections cause a self-limited syndrome comparable to other upper respiratory viral pathogens, a portion of individuals develop severe illness leading to substantial morbidity and mortality. Furthermore, an estimated 10%–20% of SARS-CoV-2 infections are followed by post-acute sequelae of COVID-19 (PASC), or long COVID. Long COVID is associated with a wide variety of clinical manifestations including cardiopulmonary complications, persistent fatigue, and neurocognitive dysfunction. Severe acute COVID-19 is associated with hyperactivation and increased inflammation, which may be an underlying cause of long COVID in a subset of individuals. However, the immunologic mechanisms driving long COVID development are still under investigation. Early in the pandemic, our group and others observed immune dysregulation persisted into convalescence after acute COVID-19. We subsequently observed persistent immune dysregulation in a cohort of individuals experiencing long COVID. We demonstrated increased SARS-CoV-2-specific CD4 + and CD8 + T-cell responses and antibody affinity in patients experiencing long COVID symptoms. These data suggest a portion of long COVID symptoms may be due to chronic immune activation and the presence of persistent SARS-CoV-2 antigen. This review summarizes the COVID-19 literature to date detailing acute COVID-19 and convalescence and how these observations relate to the development of long COVID. In addition, we discuss recent findings in support of persistent antigen and the evidence that this phenomenon contributes to local and systemic inflammation and the heterogeneous nature of clinical manifestations seen in long COVID.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. B. (2023). The role of immune activation and antigen persistence in acute and long COVID. Journal of Investigative Medicine, 71(5), 545–562. https://doi.org/10.1177/10815589231158041

MLA 9

Opsteen, Skye, et al. “The role of immune activation and antigen persistence in acute and long COVID.” Journal of Investigative Medicine, vol. 71, no. 5, 2023, pp. 545–562. https://doi.org/10.1177/10815589231158041.

Chicago

Opsteen, Skye, Jacob K. Files, Tim Fram, and Nathan B. Erdmann. 2023. “The role of immune activation and antigen persistence in acute and long COVID.” Journal of Investigative Medicine 71 (5): 545–562. https://doi.org/10.1177/10815589231158041.

Harvard

Opsteen, S. et al. (2023) ‘The role of immune activation and antigen persistence in acute and long COVID’, Journal of Investigative Medicine, 71(5), pp. 545–562. doi:10.1177/10815589231158041.

IEEE

S. Opsteen, J. K. Files, T. Fram, and N. B. Erdmann, “The role of immune activation and antigen persistence in acute and long COVID,” Journal of Investigative Medicine, vol. 71, no. 5, pp. 545–562, 2023, doi: 10.1177/10815589231158041.

BibTeX

@article{opsteen2023role,
  title     = {{The role of immune activation and antigen persistence in acute and long COVID}},
  author    = {Opsteen, Skye and Files, Jacob K. and Fram, Tim and Erdmann, Nathan B.},
  journal   = {Journal of Investigative Medicine},
  year      = {2023},
  volume    = {71},
  number    = {5},
  pages     = {545--562},
  doi       = {10.1177/10815589231158041},
  url       = {https://doi.org/10.1177/10815589231158041}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202399
20242828
20251818
20261818

Its field-weighted citation impact is 2.56: it has been cited 2.56 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19

  • long COVID
  • post-COVID-19 sequelae
  • SARS-CoV-2
  • immune activation
  • persistent antigen
  • immune dysregulation
  • T cell response
  • antibody affinity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. B. (2023). The role of immune activation and antigen persistence in acute and long COVID. Journal of Investigative Medicine, 71(5), 545–562. https://doi.org/10.1177/10815589231158041

How many times has this paper been cited?

73 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the PDF from this page.

Who wrote this paper?

Skye Opsteen, Jacob K. Files, Tim Fram, Nathan B. Erdmann.

What is the DOI of this paper?

10.1177/10815589231158041, permanently at https://doi.org/10.1177/10815589231158041. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.